As inflation continues, the IRS has announced higher health savings account (HSA) contribution limits for 2025. The boosted limits give employees more room to save and invest money for medical expenses tax-free.
2025 HSA Limits Jump Thanks to Inflation
For 2025, the HSA contribution limit for individual coverage will increase by 3.6% to $4,300, up from $4,150 in 2024. The family coverage contribution limit will go up 3% to $8,550 next year, an increase from $8,300.
While it’s welcome news for savers, the 2025 hike is notably smaller than this year’s nearly 7% inflation-fueled boost. Contribution limits have increased steadily in recent years as prices and wages grow.
HSA participation continues to expand across employer-sponsored health plans. Industry research shows account balances reached a record $123.3 billion in 2023, up 19% from the prior year. Experts say rising limits indicate strong and expanding interest in HSAs as a way to save for healthcare.
High-Deductible Health Plan Thresholds Also Climb
To be HSA-eligible, an individual must have a high-deductible health plan (HDHP) with minimum deductible and out-of-pocket maximum amounts. The IRS increased these thresholds for 2025 as well.
The minimum HDHP deductible will increase to $1,650 for individual coverage, up $50 from 2024 levels. For family plans, it will rise by $100 to $3,300 next year.
Additionally, out-of-pocket maximums will reach $8,300 for employee-only coverage and $16,600 for families in 2025. These represent respective $250 and $500 hikes. An exception applies to preventive care in HDHPs, which remains fully covered by insurance with no cost sharing.
For more Employee Benefits resources, contact INSURICA today.
Copyright © 2024 Smarts Publishing. This is not intended to be exhaustive nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel or an insurance professional for appropriate advice.
About the Author
Share This Story
Related Blogs
Fiduciary Responsibilities for Employer Health Plans: What Employers Should Know Now
When employers think about fiduciary responsibility, retirement plans often come to mind first. But recent developments make it clear that fiduciary duties also matter—sometimes significantly—when it comes to employer-sponsored health and welfare plans.
The New Era of Mental Health Parity Enforcement in 2026
Federal agencies have made mental health parity enforcement a top priority in 2026, and employers sponsoring group health plans are feeling the impact. Regulators are no longer satisfied with high‑level assurances that plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA). Instead, they expect detailed, data‑driven documentation showing that mental health and substance‑use‑disorder benefits are truly comparable to medical and surgical benefits. This includes not only the written plan design but also how rules are applied in real‑world scenarios.
The 2026 Specialty Drug Surge: What Employers Need to Prepare For
Specialty drugs have been a major cost driver for years, but 2026 marks a significant shift in both scale and urgency. With GLP 1 medications expanding into new indications, gene therapies entering the market at record pace, and oncology drugs continuing to rise in both cost and utilization, specialty medications are projected to account for more than 60% of total pharmacy spending this year. That’s a dramatic change for employers, especially considering that specialty drugs represent fewer than 5% of total prescriptions.